Journal article · 2023 · Open access
Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment
Patient Preference and Adherence, Volume 17, 1335–1345 · Published 1 June 2023 · DOI 10.2147/ppa.s378724
In brief
“Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment” is a 2023 journal article by Matthias Augustin and 4 co-authors, published in Patient Preference and Adherence. OpenAlex counts 5 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Patient Preference and Adherence.
- Citations
- 5
- Most cited in
- 2024 (3)
- Field-weighted impact
- 1.10
- References
- 35
- Authors
- 5
Abstract
Introduction: Evaluation of patient-reported outcomes including health-related quality of life (HRQoL) and perceived benefits from treatment has become a fundamental component of medical decision-making. Standardized evaluation of treatment benefits in rosacea based on patient preferences is still lacking. Objective: Development and validation of an instrument for recording patient-defined benefits in rosacea therapy based on the Patient Benefit Index (PBI) methodology. Patients and Methods: In an open survey of n = 50 patients, potential benefits of therapy from the patient's perspective were examined. The generated item pool was combined with pre-existing PBI items for other skin conditions and reviewed by an expert panel of dermatologists, psychologists and patients. Items were condensed to n = 25 and converted into a Likert-scaled questionnaire. The validity and feasibility of the resulting Patient Benefit Index for rosacea (PBI-RO) were tested on individuals with rosacea recruited from a German rosacea patient organization. Results: N = 446 patients with rosacea completed the PBI-RO. The internal consistencies measured by Cronbach's alpha were high (Patient Needs Questionnaire [PNQ] 0.94). Mean PBI-RO was 1.9 ± 1.2 (scale from 0 = no benefit to 4 = maximum benefit), 23.5% of the patients experienced a PBI-RO < 1 (no clinically relevant benefit). The PBI-RO correlated with HRQoL, health state, current extent of rosacea lesions and treatment satisfaction. The highest correlation was found between PBI-RO and satisfaction with previous treatment (r = -0.59, p < 0.001); correlation with the extent of rosacea lesions was low (r = 0.16, p < 0.001). Conclusion: The PBI-RO shows satisfying internal consistency and construct validity. It offers the option of a patient-weighted evaluation of the therapeutic benefit of rosacea therapy and may add to more stringent goal orientation in therapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Augustin, M., Sommer, R., Blome, C., Kirsten, N., & Langenbruch, A. K. (2023). Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment. Patient Preference and Adherence, Volume 17, 1335–1345. https://doi.org/10.2147/ppa.s378724
MLA 9
Augustin, Matthias, et al. “Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment.” Patient Preference and Adherence, vol. Volume 17, 2023, pp. 1335–1345. https://doi.org/10.2147/ppa.s378724.
Chicago
Augustin, Matthias, Rachel Sommer, Christine Blome, Natalia Kirsten, and Anna Katharina Langenbruch. 2023. “Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment.” Patient Preference and Adherence Volume 17: 1335–1345. https://doi.org/10.2147/ppa.s378724.
Harvard
Augustin, M. et al. (2023) ‘Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment’, Patient Preference and Adherence, Volume 17, pp. 1335–1345. doi:10.2147/ppa.s378724.
IEEE
M. Augustin, R. Sommer, C. Blome, N. Kirsten, and A. K. Langenbruch, “Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment,” Patient Preference and Adherence, vol. Volume 17, pp. 1335–1345, 2023, doi: 10.2147/ppa.s378724.
BibTeX
@article{augustin2023development,
title = {{Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment}},
author = {Augustin, Matthias and Sommer, Rachel and Blome, Christine and Kirsten, Natalia and Langenbruch, Anna Katharina},
journal = {Patient Preference and Adherence},
year = {2023},
volume = {Volume 17},
pages = {1335--1345},
doi = {10.2147/ppa.s378724},
url = {https://doi.org/10.2147/ppa.s378724}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 3 | |
| 2025 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 1.10: it has been cited 1.10 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Patient Benefit Index
- rosacea
- patient-reported outcomes
- perceived treatment benefit
- health-related quality of life
- treatment satisfaction
- patient preferences
- questionnaire development
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Augustin, M., Sommer, R., Blome, C., Kirsten, N., & Langenbruch, A. K. (2023). Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment. Patient Preference and Adherence, Volume 17, 1335–1345. https://doi.org/10.2147/ppa.s378724
How many times has this paper been cited?
5 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Patient Preference and Adherence: sign in and open the PDF from this page.
Who wrote this paper?
Matthias Augustin, Rachel Sommer, Christine Blome, Natalia Kirsten, Anna Katharina Langenbruch.
What is the DOI of this paper?
10.2147/ppa.s378724, permanently at https://doi.org/10.2147/ppa.s378724. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.